The Latest Breaking News from BSX

Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects.

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

Boston Scientific is expected to report its second-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

Boston Scientific's first-quarter sales guidance is "impressive," an analyst said Wednesday as BSX stock hit a record high.

Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.

The medical devices and equipment industry is primed to make significant strides toward growth this year, a surge propelled by increasing incidences of chronic diseases and the emphasis on early detection and treatment, coupled with leaps in technological development. Given this backdrop, let’s compare medical device stocks Boston Scientific (BSX)…

Boston Scientific beat third-quarter expectations, but Edwards Lifesciences' metrics were just in line. Shares of both tumbled.

Boston Scientific kicked off its Investor Day on Wednesday, a day after announcing its Relievant buyout, and BSX stock jumped.

Boston Scientific is likely to win FDA approval for a new method of treating abnormal heartbeats. BSX stock surged on its Phase 3 win.